glp 1 drugs anti inflammatory Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases GLP-1 Agonists: The Anti-Inflammatory Revolution

Description

Weight loss of 15% or greater was achieved by 66.7% of participants at 9 mg and 75.0% at 10 mg, indicating robust responses across most participants rather than outlier-driven averages

Additionally, the neuroprotective effects of GLP1RAs have been shown to be achieved through multiple mechanisms

Interestingly, in a retrospective study of 186 patients (56% type 1 diabetes mellitus) from the Netherlands, dyspeptic symptoms, with the exception of early satiety and abdominal pain, were unrelated to delayed gastric emptying [69]

These include early pharmacokinetic limitations, inadequate receptor selectivity, poorly chosen clinical endpoints, or the absence of enabling technologies at the time of initial evaluation